Cell Transformation by V-Rel Reveals Distinct Roles of AP-1 Family Members in Rel/NF-kappaB Oncogenesis
Overview
Authors
Affiliations
Cell transformation by the v-rel oncogene is mediated by the aberrant expression of genes that are normally tightly regulated by other Rel/NF-kappaB family members. Although a number of genes inappropriately activated or suppressed by v-Rel have been identified, their contributions to the v-Rel transformation process have been poorly characterized. Here, we examine the role of individual AP-1 proteins in v-Rel-mediated transformation. v-Rel-transformed cells exhibit elevated RNA and protein expression of c-Fos, c-Jun and ATF2 and sustained repression of Fra-2. c-Fos and c-Jun are essential in both the initiation and maintenance of v-Rel-mediated transformation, whereas Fra-2 is dispensable. By employing a c-Jun dimerization mutant, we further identified Fos/Jun heterodimers as major contributors to the v-Rel transformation process. The inability of c-Rel to induce the expression of c-Fos and c-Jun contributes to its weaker oncogenic potential relative to v-Rel. Our studies also demonstrate that v-Rel may induce AP-1 members by directly upregulating gene expression (c-fos and ATF2) and by activating pathways that stimulate AP-1 activity. Although elevated expression of ATF2 is also required for v-Rel-mediated transformation, its ectopic overexpression is inhibitory. Investigating the mode of ATF2 regulation revealed a positive feedback mechanism whereby ATF2 induces p38 MAPK phosphorylation to further induce its own activity. In addition, these studies identified Ha-Ras as an effector of v-Rel-mediated transformation and reveal a novel role for ATF2 in the inhibition of the Ras-Raf-MEK-ERK signaling pathway. Overall, these studies reveal distinct and complex roles of AP-1 proteins in Rel/NF-kappaB oncogenesis.
Inhibition of v--Induced Oncogenesis through microRNA Targeting.
Yao Y, Zhang Y, Tang N, Pedrera M, Shen Z, Nair V Viruses. 2018; 10(5).
PMID: 29734737 PMC: 5977235. DOI: 10.3390/v10050242.
Riedlinger T, Haas J, Busch J, van de Sluis B, Kracht M, Schmitz M Biomedicines. 2018; 6(1).
PMID: 29562713 PMC: 5874693. DOI: 10.3390/biomedicines6010036.
Yao Y, Vasoya D, Kgosana L, Smith L, Gao Y, Wang X J Gen Virol. 2017; 98(4):810-820.
PMID: 28113043 PMC: 5657028. DOI: 10.1099/jgv.0.000718.
Dyshlovoy S, Fedorov S, Shubina L, Kuzmich A, Bokemeyer C, Keller-von Amsberg G Biomed Res Int. 2014; 2014:469309.
PMID: 25215281 PMC: 4158141. DOI: 10.1155/2014/469309.
Liss A, Bose H Small GTPases. 2011; 2(2):89-94.
PMID: 21776408 PMC: 3136910. DOI: 10.4161/sgtp.2.2.15310.